Russia's sovereign wealth fund has filed for registration of Sputnik V in the European Union and expects it to be reviewed in February, the official account promoting the COVID-19 vaccine tweeted on Wednesday.
The Sputnik V and European Medical Agency (EMA) teams held a scientific review of the vaccine on Tuesday, the Sputnik V account said, adding the EMA will take a decision on the authorization of the vaccine based on the reviews. (https://bit.ly/39OQZDR)
The vaccine has already been approved in Argentina, Belarus, Serbia and other countries.
Netanyahu says Israel will escalate strikes against Hezbollah
WHO chief says fast-moving Ebola epidemic outpacing response efforts
Iran's president orders restoration of international internet access: State media
Brazil's Lula starts radiation after early-stage skin cancer diagnosis
